Cargando…

Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer

PURPOSE: To observe the remission rate and side effects of immunotherapy combined with radiotherapy in patients with brain metastasis of driver gene-negative non-small-cell lung cancer (NSCLC). METHODS: 152 patients with NSCLC brain metastasis admitted to our hospital from January 2019 to December 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qun, Zhou, Shixiang, Yin, Hongmei, Zhu, Chaomang, Li, Duojie, Li, Xianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550440/
https://www.ncbi.nlm.nih.gov/pubmed/36225182
http://dx.doi.org/10.1155/2022/1193075
_version_ 1784805885906780160
author Zhang, Qun
Zhou, Shixiang
Yin, Hongmei
Zhu, Chaomang
Li, Duojie
Li, Xianming
author_facet Zhang, Qun
Zhou, Shixiang
Yin, Hongmei
Zhu, Chaomang
Li, Duojie
Li, Xianming
author_sort Zhang, Qun
collection PubMed
description PURPOSE: To observe the remission rate and side effects of immunotherapy combined with radiotherapy in patients with brain metastasis of driver gene-negative non-small-cell lung cancer (NSCLC). METHODS: 152 patients with NSCLC brain metastasis admitted to our hospital from January 2019 to December 2021 were selected as the research objects. Patients were divided into a single group (85 cases) and a combined group (67 cases) according to treatment methods. The therapeutic effects and side effects of the single group and combined group were compared. In addition, the patients who received immunotherapy combined with radiotherapy were divided into three subgroups: A, B, and C, and the therapeutic effects and side effects of different radiotherapy modes were compared among group A [whole brain radiotherapy (WBRT)], group B (WBRT combined with local radiotherapy) and group C (local radiotherapy). RESULTS: The objective response rate (ORR) and disease control rate (DCR) in the combined group were higher than those in the single group (P < 0.05). The incidence of reactive capillary hyperplasia and immune-related pneumonia in the combined group were higher than that in the single group (P < 0.05). There was no significant difference in the incidence of other side effects between the two groups (P > 0.05). ORR and DCR in group B were higher than those in group A (P < 0.05). There was no significant difference in the incidence of side effects among the three groups (P > 0.05). CONCLUSION: Immunotherapy combined with radiotherapy is effective in patients with brain metastasis of driver gene-negative NSCLC, which can improve the disease control rate without increasing the side effects. In addition, WBRT combined with local push radiotherapy is effective and safe. Clinical Study Registration Number. The Clinical study registration number is K2019086.
format Online
Article
Text
id pubmed-9550440
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95504402022-10-11 Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer Zhang, Qun Zhou, Shixiang Yin, Hongmei Zhu, Chaomang Li, Duojie Li, Xianming Evid Based Complement Alternat Med Research Article PURPOSE: To observe the remission rate and side effects of immunotherapy combined with radiotherapy in patients with brain metastasis of driver gene-negative non-small-cell lung cancer (NSCLC). METHODS: 152 patients with NSCLC brain metastasis admitted to our hospital from January 2019 to December 2021 were selected as the research objects. Patients were divided into a single group (85 cases) and a combined group (67 cases) according to treatment methods. The therapeutic effects and side effects of the single group and combined group were compared. In addition, the patients who received immunotherapy combined with radiotherapy were divided into three subgroups: A, B, and C, and the therapeutic effects and side effects of different radiotherapy modes were compared among group A [whole brain radiotherapy (WBRT)], group B (WBRT combined with local radiotherapy) and group C (local radiotherapy). RESULTS: The objective response rate (ORR) and disease control rate (DCR) in the combined group were higher than those in the single group (P < 0.05). The incidence of reactive capillary hyperplasia and immune-related pneumonia in the combined group were higher than that in the single group (P < 0.05). There was no significant difference in the incidence of other side effects between the two groups (P > 0.05). ORR and DCR in group B were higher than those in group A (P < 0.05). There was no significant difference in the incidence of side effects among the three groups (P > 0.05). CONCLUSION: Immunotherapy combined with radiotherapy is effective in patients with brain metastasis of driver gene-negative NSCLC, which can improve the disease control rate without increasing the side effects. In addition, WBRT combined with local push radiotherapy is effective and safe. Clinical Study Registration Number. The Clinical study registration number is K2019086. Hindawi 2022-09-23 /pmc/articles/PMC9550440/ /pubmed/36225182 http://dx.doi.org/10.1155/2022/1193075 Text en Copyright © 2022 Qun Zhang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhang, Qun
Zhou, Shixiang
Yin, Hongmei
Zhu, Chaomang
Li, Duojie
Li, Xianming
Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
title Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
title_full Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
title_fullStr Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
title_full_unstemmed Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
title_short Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
title_sort analysis of immunotherapy combined with radiotherapy in patients with brain metastasis of driver gene-negative non-small-cell lung cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550440/
https://www.ncbi.nlm.nih.gov/pubmed/36225182
http://dx.doi.org/10.1155/2022/1193075
work_keys_str_mv AT zhangqun analysisofimmunotherapycombinedwithradiotherapyinpatientswithbrainmetastasisofdrivergenenegativenonsmallcelllungcancer
AT zhoushixiang analysisofimmunotherapycombinedwithradiotherapyinpatientswithbrainmetastasisofdrivergenenegativenonsmallcelllungcancer
AT yinhongmei analysisofimmunotherapycombinedwithradiotherapyinpatientswithbrainmetastasisofdrivergenenegativenonsmallcelllungcancer
AT zhuchaomang analysisofimmunotherapycombinedwithradiotherapyinpatientswithbrainmetastasisofdrivergenenegativenonsmallcelllungcancer
AT liduojie analysisofimmunotherapycombinedwithradiotherapyinpatientswithbrainmetastasisofdrivergenenegativenonsmallcelllungcancer
AT lixianming analysisofimmunotherapycombinedwithradiotherapyinpatientswithbrainmetastasisofdrivergenenegativenonsmallcelllungcancer